image
Myriad Genetics, Inc. MYGN
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 4.07
-8.54 %
$ 375 M
Market Cap
-3.63
P/E
Price Target Average
424.91%
Revenue Forecast Estimate
7.17%
EBIT Estimate
0.60%
Net Income Estimate
20.63%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Myriad Genetics, Inc.
image
Wall Street analysts predict an average 1-year price target for MYGN of $21.4 , with forecasts ranging from a low of $6 to a high of $35 .
MYGN Lowest Price Target Wall Street Target
6 USD 47.42%
MYGN Average Price Target Wall Street Target
21.4 USD 424.91%
MYGN Highest Price Target Wall Street Target
35 USD 759.95%
Price
Max Price Target
Min Price Target
Average Price Target
3535303025252020151510105500Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart MYGN

image
$1.0b$1.0b$900.0m$900.0m$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart MYGN

image
$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)($1.4b)($1.4b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart MYGN

image
$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029